Importantly, we found that PD-L1 expression is up-regulated in platelets and PBMCs independently of tumor stage (N−, stage I and II; N+ stage III and IV), and is already enhanced in platelets and PBMCs from smokers, which are under increased risk to develop HNSCC or lung cancer. The gene discussed is CD274; the disease is lung carcinoma.